m+Medelevator.RU
← Поиск публикаций
MCN. The American journal of maternal child nursing · 2025

Less Invasive Surfactant Administration: A Quality Improvement Project.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Orr Krystal, Bergman Greta, Gall Gloria

Аннотация

PURPOSE: Less invasive surfactant administration (LISA) uses a thin catheter that allows infants to breathe spontaneously throughout surfactant administration. The procedure potentially reduces adverse effects and enhances clinical outcomes compared to the INtubate, SURfactant, Extubate (INSURE) method, which requires transient intubation with an endotracheal tube and positive pressure ventilation. The purpose is to share how the Plan-Do-Study-Act (PDSA) cycle method can identify improvement opportunities, guide interventions, and improve outcomes in a LISA quality improvement (QI) initiative via interprofessional collaboration.

METHODS: A QI project was implemented via an interprofessional team using PDSA cycles in a 63-bed level III neonatal intensive care unit. Compliance rates, infant outcomes, and clinician feedback were analyzed and discussed monthly. An interprofessional team developed a step-by-step LISA checklist and LISA video, improved equipment storage, standardized charting, and rolled out re-education.

RESULTS: Implementation of this quality project increased compliance levels of LISA (16 infants pre-project, 43 infants post-project) in place of INSURE (16 infants pre-project, 4 post-project) from 47% to a consistent 100% for eligible infants by 2 months after the project implementation. It also improved multiple outcome measures for the LISA procedure, including a reduction of grade III and IV intraventricular hemorrhage (IVH), a decrease in the percentage of infants requiring a second surfactant dose, and a decrease in chronic lung disease (CLD). LISA was expanded to other hospitals in the physician group's network.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты